Bank Of Marin Bancorp quarterly report, Q1 FY2020

Bank of Marin Bancorp — Q1 2020 Form 10-Q

Business context and reporting period. The filing covers the three months ended March 31, 2020. Bank of Marin Bancorp is a California bank holding company whose principal subsidiary is Bank of Marin. Results reflect the initial effects of the COVID-19 pandemic and related economic uncertainty.

Financial performance and position

MetricQ1 2020 / Mar. 31, 2020Comparison
Net interest income$24.1 million$23.8 million in Q1 2019
Provision for loan losses$2.2 millionNone in Q1 2019
Non-interest income$3.1 million$1.8 million in Q1 2019
Non-interest expense$15.5 million$15.5 million in Q1 2019
Net income / diluted EPS$7.2 million / $0.53$7.5 million / $0.54 in Q1 2019
Tax-equivalent net interest margin3.88%4.02% in Q1 2019
Return on assets / equity1.09% / 8.54%1.19% / 9.54% in Q1 2019
Total assets$2.698 billion$2.707 billion at Dec. 31, 2019
Loans, net / deposits$1.825 billion / $2.307 billion$1.827 billion / $2.336 billion at Dec. 31, 2019
Cash, cash equivalents and restricted cash$156.3 million$183.4 million at Dec. 31, 2019
Operating cash flow$9.5 million$10.5 million in Q1 2019
Equity / total capital ratio (Bancorp)$345.9 million / 15.29%$336.8 million / 15.07% at Dec. 31, 2019

Other key metrics. The allowance for loan losses was $18.9 million, or 1.02% of loans, versus $16.7 million, or 0.90%, at year-end. Non-accrual loans were $1.6 million (0.09% of loans), up from $226,000 (0.01%). The efficiency ratio was 56.79%, compared with 60.62% in Q1 2019. Average deposit cost was 0.21%, versus 0.18%.

Material changes versus comparable periods

  • Net income declined $251,000 year over year, principally reflecting the $2.2 million credit-loss provision associated with pandemic-related uncertainty. Management estimated that provision reduced diluted EPS by about $0.12.
  • Higher non-interest income partly offset the provision: investment-security sale gains were $800,000 versus a $6,000 loss in Q1 2019. Management also cited accelerated discount accretion on a called security; together, these items were estimated to add about $0.07 to diluted EPS.
  • Net interest income rose $273,000, but the tax-equivalent margin fell 14 basis points, reflecting lower asset yields, higher cash balances and higher rates on some deposit categories.
  • Loans were nearly flat quarter over quarter. Deposits decreased $29.4 million, chiefly attributed to normal cash fluctuations in large commercial accounts. Non-interest-bearing deposits were $1.130 billion, about 49% of deposits.
  • Available-for-sale securities’ fair value increased, contributing to accumulated other comprehensive income; stockholders’ equity rose to $345.9 million from $336.8 million at year-end.

Outlook, management commentary and risks

  • Management said strong liquidity, capital, credit quality and a low-cost deposit base should help the bank navigate the pandemic and low-rate environment, but cautioned that future effects were uncertain. No earnings or revenue guidance was provided.
  • Management anticipated an annual net interest income reduction of $750,000–$1.0 million from lowered interest-rate floors on primarily commercial Prime-based loans. Federal Reserve rate cuts were expected to pressure asset yields and margins in subsequent quarters.
  • As of April 30, the bank had approved 253 COVID-related payment deferrals covering $358 million in loans, generally for up to 120 days. It also had SBA approval for 1,452 Paycheck Protection Program applications totaling $294 million; most were funded or expected to be funded shortly. These are subsequent-period figures, not Q1 balances.
  • Loan exposure to industries identified as most affected included retail properties and businesses (10.4%), wine-related businesses (4.6%) and hospitality (2.7%). Management reported that 96% of approved deferral requests were secured by real estate, with average loan-to-value ratios below 46%.
  • Available unencumbered securities and cash totaled $517.9 million at quarter-end. The bank also reported unused borrowing capacity, including $676.8 million under FHLB lines and $79.3 million under its Federal Reserve line; neither facility had outstanding borrowings. Undrawn loan commitments and standby letters of credit totaled $488.9 million.
  • Both Bancorp and the Bank exceeded regulatory well-capitalized thresholds. Bancorp’s total risk-based capital ratio was 15.29%; the Bank’s was 14.40%.
  • The CARES Act allowed the company to postpone CECL adoption. The filing estimated that, based on pre-pandemic forecasts, adopting CECL on January 1, 2020 would have increased the year-end 2019 allowance by 5%–15%; this estimate excluded the subsequent pandemic impact.
  • The board suspended the share repurchase program indefinitely on March 20 to prioritize customer needs. Q1 repurchases totaled $3.2 million. A $0.23-per-share dividend was declared April 17, payable May 8.
  • Principal risks include pandemic duration and economic effects, borrower stress and collateral values, deposit outflows, lower interest rates and margins, potential credit-loss increases, market volatility affecting wealth-management income, and operational or cybersecurity disruption. Management reported no known pending legal proceeding expected to have a material adverse effect; Visa-related litigation indemnification exposure remains contingent on settlement outcomes, with no liability recorded because losses were considered remote.

Most important facts for investors to verify

  1. Whether pandemic-related borrower deferrals, industry concentrations and economic deterioration lead to higher delinquencies, non-accrual loans, charge-offs or allowance needs.
  2. Whether the reported $750,000–$1.0 million annual net interest income impact and further rate changes materially reduce margin and earnings.
  3. Actual PPP loan funding, forgiveness, fees and associated credit or operational effects after quarter-end.
  4. Deposit trends, use of the $488.9 million in commitments, and whether reported liquidity and available borrowing capacity remain adequate under stress.
  5. How CECL adoption timing and pandemic-era economic forecasts affect the allowance and capital; the filing’s 5%–15% estimate is based on pre-pandemic forecasts.
  6. Whether the share repurchase suspension, dividend, and Visa-related litigation developments change capital deployment or contingent exposure.